Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 18:59 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
TCR-T Cell Therapy on Advanced Solid Tumors
NCT05438667 · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · EARLY_PHASE1 · terminated · last registry update 2026-09-01 · Pancreatic cancer · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “In light of the impending acquisition of the project partner, Shanghai Bintie Biotechnology Co., Ltd., the company has resolved to close all IT centers and discontinue the clinical research project.” | – | Registry record, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
Also happening at the time. Not shown to be a cause.
No drug target was found for this trial's interventions, so there is no same-target timeline.
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision